ALKS · NASDAQ · Drug Manufacturers - Specialty & Generic

Alkermes (ALKS)

Develops and sells neuroscience medicines spanning addiction, psychiatry and sleep disorders.

$43.70
vs last close−0.48 (−1.09%)
  1. Why Is Alkermes (ALKS) Up 1.7% Since Last Earnings Report?

    Zacks Investment ResearchMarket move